Corteva (NYSE:CTVA) Price Target Raised to $97.00 at Royal Bank Of Canada

Corteva (NYSE:CTVA) had its target price hoisted by Royal Bank Of Canada from $95.00 to $97.00 in a research note released on Thursday,MarketScreener reports. The brokerage currently has an outperform rating on the stock.

A number of other equities analysts have also recently weighed in on CTVA. Citigroup upped their price target on shares of Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Mizuho lifted their price target on shares of Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a research report on Wednesday, April 15th. Finally, Wall Street Zen lowered Corteva from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $87.05.

Corteva Stock Performance

CTVA traded up $1.29 during trading on Thursday, reaching $80.36. The company’s stock had a trading volume of 1,109,528 shares, compared to its average volume of 3,990,583. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.47. The company’s fifty day moving average price is $80.68 and its 200-day moving average price is $72.61. Corteva has a 52-week low of $60.53 and a 52-week high of $85.63. The company has a market capitalization of $53.95 billion, a price-to-earnings ratio of 47.26, a price-to-earnings-growth ratio of 2.81 and a beta of 0.59.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the prior year, the business posted $1.13 EPS. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts forecast that Corteva will post 3.62 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s payout ratio is currently 42.35%.

Insider Activity

In related news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.15% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. Harris Associates L P lifted its position in Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after buying an additional 10,675,052 shares during the period. Norges Bank acquired a new position in shares of Corteva during the 4th quarter valued at about $504,001,000. Northwestern Mutual Wealth Management Co. increased its stake in shares of Corteva by 6,527.4% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock valued at $211,025,000 after acquiring an additional 3,100,709 shares during the last quarter. Perpetual Ltd lifted its holdings in shares of Corteva by 78,688.5% during the 4th quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock worth $175,336,000 after acquiring an additional 2,612,459 shares during the period. Finally, Amundi lifted its holdings in shares of Corteva by 125.3% during the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock worth $219,620,000 after acquiring an additional 1,899,248 shares during the period. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Trending Headlines about Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Jefferies raised its Corteva price target to $97 (from $95), reiterating a bullish view and implying ~22% upside — a strong analyst endorsement that can lift investor sentiment. Jefferies price target raise to $97
• Positive Sentiment: RBC Capital Markets increased its price target to $97 and kept an “outperform” rating — another high‑profile upgrade supporting upside expectations and reinforcing positive momentum. RBC raises target to $97
• Neutral Sentiment: UBS raised its price target to $90 but kept a “neutral” rating — the higher target narrows upside skepticism but the neutral stance tempers the immediate bullish impact. UBS target to $90 (Benzinga)
• Neutral Sentiment: Citigroup nudged its target to $85 and kept a “neutral” rating — a modest increase that likely has limited directional impact compared with larger upgrades. Citigroup raises target to $85
• Neutral Sentiment: Corteva will present at the BMO Global Farm to Market conference (CEO Chuck Magro and CFO David Johnson on May 14) — a near‑term catalyst that could move the stock if management provides incremental guidance or updates. Corteva to participate in BMO conference
• Neutral Sentiment: Q1 2026 earnings call/transcripts are available for investors who want detail on drivers (revenue beat, EPS beat, and FY26 guidance were provided earlier) — useful for fundamentals confirmation but not an immediate new development. Q1 2026 earnings transcript (Yahoo) Q1 call transcript (Seeking Alpha)
• Negative Sentiment: BNP Paribas Exane raised its target to $77, which remains below the current price — this implies limited or negative upside from that house and could weigh on investors who follow BNP’s view. BNP raises target to $77 (still below market)

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.